Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 995-1000. doi: 10.19723/j.issn.1671-167X.2020.06.002
Previous Articles Next Articles
Feng-yun-zhi ZHU1,Xiao-yan XING2,Xiao-fei TANG3,Yi-min LI1,Miao SHAO1,Xue-Wu ZHANG1,Yu-hui LI1,△(),Xiao-lin SUN1,Jing HE1
CLC Number:
[1] |
Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017,69(12):2271-2282.
doi: 10.1002/art.40320 pmid: 29106061 |
[2] |
Ogdie A, Kay McGill N, Shin DB, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A general population-based cohort study[J]. Eur Heart J, 2018,39(39):3608-3614.
doi: 10.1093/eurheartj/ehx145 pmid: 28444172 |
[3] |
Aviña-Zubieta JA, Vostretsova K, De Vera MA, et al. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study[J]. Semin Arthritis Rheum, 2015,45(2):195-201.
doi: 10.1016/j.semarthrit.2015.05.008 pmid: 26364556 |
[4] |
Carruthers EC, Choi HK, Sayre EC, et al. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: A general population-based study[J]. Ann Rheum Dis, 2016,75(1):110-116.
doi: 10.1136/annrheumdis-2014-205800 pmid: 25193998 |
[5] | Antovic A, Notarnicola A, Svensson J, et al. Venous thromboembolic events in idiopathic inflammatory myopathy: Occurrence and relation to disease onset[J]. Arthritis Care Res (Hoboken), 2018,70(12):1849-1855. |
[6] | Bohan A, Peter J B. Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):403-407. |
[7] |
Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyo-pathies spectrum of clinical illness?[J]. J Am Acad Dermatol, 2002,46(4):626-636.
pmid: 11907524 |
[8] |
Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute[J]. Circulation, 2006,113(19):2363-2372.
pmid: 16702489 |
[9] |
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis, 2016,41(1):3-14.
pmid: 26780736 |
[10] |
Holmqvist M, Ljung L, Askling J. Acute coronary syndrome in new-onset rheumatoid arthritis: A population-based nationwide cohort study of time trends in risks and excess risks[J]. Ann Rheum Dis, 2017,76(10):1642-1647.
doi: 10.1136/annrheumdis-2016-211066 pmid: 28710095 |
[11] | Schoenfeld SR, Choi HK, Sayre EC, et al. Risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: A general population-based study[J]. Arthritis Care Res (Hoboken), 2016,68(2):246-253. |
[12] | Zöller B, Li X, Sundquist J, et al. Risk of pulmonary embolism in patients with autoimmune disorders: A nationwide follow-up study from Sweden[J]. Lancet, 2012,379(9812):244-249. |
[13] |
Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation[J]. Hamostaseologie, 2010,30(1):5-9.
pmid: 20162248 |
[14] |
Choi HK, Rho YH, Zhu Y, et al. The risk of pulmonary embo-lism and deep vein thrombosis in rheumatoid arthritis: A UK population-based outpatient cohort study[J]. Ann Rheum Dis, 2013,72(7):1182-1187.
pmid: 22930596 |
[15] |
Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism[J]. Crit Rev Oncol Hematol, 2016,99:272-285.
doi: 10.1016/j.critrevonc.2016.01.007 pmid: 26811138 |
[16] | Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis [J/OL]. Front Immunol, (2019-02-04)[2020-04-30]. doi: 10.3389/fimmu.2019.00085. |
[17] | Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: Record-linkage study [J/OL]. BMC Med, (2011-01-10)[2020-04-30]. doi: 10.1186/1741-7015-9-1. |
[1] | Yun-shu XIAO,Feng-yun-zhi ZHU,Lan LUO,Xiao-yan XING,Yu-hui LI,Xue-wu ZHANG,Dan-hua SHEN. Clinical and immunological characteristics of 88 cases of overlap myositis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1088-1093. |
[2] | Lan LUO,Xiao-yan XING,Yun-shu XIAO,Ke-yan CHEN,Feng-yun-zhi ZHU,Xue-wu ZHANG,Yu-hui LI. Clinical and immunological characteristics of patients with anti-synthetase syndrome complicated with cardiac involvement [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1078-1082. |
[3] | Pu-li ZHANG,Hong-xia YANG,Li-ning ZHANG,Yong-peng GE,Qing-lin PENG,Guo-chun WANG,Xin LU. Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1055-1060. |
[4] | Wen-xia YI,Cui-jie WEI,Ye WU,Xin-hua BAO,Hui XIONG,Xing-zhi CHANG. Long-term rituximab treatment of refractory idiopathic inflammatory myopathy: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1191-1195. |
[5] | Yi-ming ZHENG,Hong-jun HAO,Yi-lin LIU,Jing GUO,Ya-wen ZHAO,Wei ZHANG,Yun YUAN. Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1088-1092. |
[6] | Yu-zhou GAN,Yu-hui LI,Li-hua ZHANG,Lin MA,Wen-wen HE,Yue-bo JIN,Yuan AN,Zhan-guo LI,Hua YE. Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1001-1008. |
[7] | Jing ZHAO,Feng SUN,Yun LI,Xiao-zhen ZHAO,Dan XU,Ying-ni LI,Yu-hui LI,Xiao-lin SUN. Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1009-1013. |
[8] | Hong-xia YANG,Xiao-lan TIAN,Wei JIANG,Wen-li LI,Qing-yan LIU,Qing-lin PENG,Guo-chun WANG,Xin LU. Clinical and pathological characteristics of immune mediated necrotizing myopathy [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 989-995. |
[9] | Jiao-niu DUAN,Wei DU,Rui-hong HOU,Ke XU,Gai-lian ZHANG,Li-yun ZHANG. Progressive necrosis of lipid: A case report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1182-1184. |
[10] | Jing XU,Jing XU,He LI,Jie TANG,Jian-long SHU,Jing ZHANG,Lian-jie SHI,Sheng-guang LI. Dermatomyositis combined with IgA vasculitis: A case report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1173-1177. |
[11] | Zhi-gang ZHANG,Xin-min LIU. Clinical characteristics of patients with acute renal infarction: an analysis of 52 patients in a single center [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 863-869. |
[12] | Wei ZHANG,Pei-xun ZHANG. Analysis of prophylactic effect of extended-duration anticoagulant drugs in elderly patients undergoing hip fracture [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 501-504. |
[13] | Yi-ying YANG,Xiao-xia ZUO,Hong-lin ZHU,Si-jia LIU. Advances in epigenetic markers of dermatomyositis/polymyositis [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 374-377. |
[14] | Xing-yun ZHU,Yan-ying LIU,Xue-juan SUN,Ping YU,Shuang LIU,Mei-yan FU,Xu LIU,Li-min REN,Zhan-guo LI. A cross-sectional study of the clinical features and physician visit patterns at onset of immunoglobulin G4 related disease [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1039-1043. |
[15] | Jie-yu GU,Cui LU,Hui SHI,Cheng-de YANG. Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1033-1038. |